Risk factors associated with development of atrial fibrillation early after coronary artery bypass grafting.
Cağli
K
K
Türkiye Yüksek Ihtisas Hospital, Cardiovascular Surgery Clinic, Ankara, Turkey.
Göl
M K
MK
Keles
T
T
Sener
E
E
Yildiz
U
U
Uncu
H
H
Taşdemir
O
O
Bayazit
K
K
D001281:Atrial Fibrillation / Q000188:drug therapy / Q000209:etiology*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002303:Cardiac Output, Low / Q000150:complications*; D016022:Case-Control Studies; D017023:Coronary Angiography; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000503:physiopathology / Q000601:surgery*; D004070:Digitalis / Q000627:therapeutic use; D004110:Diltiazem / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006439:Hemodynamics; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology*; D011446:Prospective Studies; D012307:Risk Factors
D002121:Calcium Channel Blockers; D004110:Diltiazem